참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Imidazole | HCID 795 | — |
| 반응물 | tert-Butyldimethylsilyl chloride | HCID 28928 | — |
| 반응물 | 2-Bromo-5-(trifluoromethyl)benzyl alcohol | HCID 2756248 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | (2-Bromo-5-(trifluoromethyl)benzyloxy)(tert-butyl)dimethylsilane | HCID 58968745 | 97.2% |
반응 단계
To a solution of (2-bromo-5-(trifluoromethyl)phenyl)methanol (from Preparation 2, 10 g, 39 mmol) in DMF (20 mL) was added imidazole (5.87 g, 86.3 mmol) followed by t-butyldimethylsilyl chloride (7.11 g, 47.2 mmol) and the reaction was stirred at room temperature for 16 hours. The mixture was partitioned between ethyl acetate and water. The organic layer was washed with brine, dried over sodium sulfate and concentrated in vacuo. The residue was purified by chromatography over 25+M Biotage silica column (eluted with 0-20% ethyl acetate in heptane) (5CV), 20% (1 CV) to afford a colorless oil (14 g, 97%) of the title compound. 1H NMR (400 MHz, CDCl3) δ ppm 0.15 (s, 6H) 0.98 (s, 9H) 4.75 (s, 2H) 7.36 (m, 1H) 7.60 (d, J=8.3 Hz, 1H) 7.84 (s, 1H)). GCMS: 311 (M-57, t-bu).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07919506B2 |
|---|
| 출처 데이터셋 | uspto-grants-2011_04 |
|---|
| ORD ID | ord-d1a4daba6f1c421d9888d925c3e03bd6 |
|---|
| 출처 메모 | uspto-grants-2011_04 |
|---|